Athira Pharma Inc
(NAS:ATHA)
$
3.32
0.21 (6.75%)
Market Cap: 127.62 Mil
Enterprise Value: 37.26 Mil
PE Ratio: 0
PB Ratio: 1.43
GF Score: 41/100 Athira Pharma Inc (ATHA) Transcripts
- Athira Pharma Inc at Jefferies CNS & Neuro Summit TranscriptOct 12, 2023
- Athira Pharma Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Athira Pharma Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Athira Pharma Inc Annual Shareholders Meeting TranscriptMay 18, 2023
- Athira Pharma Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Athira Pharma Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Athira Pharma Inc at Needham Neuroscience Forum (Virtual) TranscriptMar 15, 2023
- Athira Pharma Inc at Stifel Healthcare Conference TranscriptNov 16, 2022
- Athira Pharma Inc To Discuss The ACT-AD Results TranscriptJun 22, 2022
- Athira Pharma Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Q4 2021 Athira Pharma Inc Earnings Call TranscriptMar 24, 2022$11.87 (+5.60%)Earnings
- 1